Leqembi: Alzheimer’s drug from Eisai and Biogen faces setback
The European Union's drugs regulator has rejected Eisai and Biogen's Leqembi treatment for early Alzheimer's… Read More
1 year ago
Eisai
Pharmaceutical starts phase three trials for second Alzheimer’s drug
Eisai Co Ltd on Friday said it has begun phase 3 clinical trials of Alzheimer’s… Read More
6 years ago